MedPath

HYPAQUE-M LIQ 76% USP

HYPAQUE-M LIQ 76% USP

Discontinued
DIN Number

01904841

Drug Class

Human

Market Date

Dec 31, 1992

Company
HC

sterling winthrop inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01904841
AIG Number0201807001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08AA01 DIATRIZOIC ACID
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification36:68.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

DIATRIZOATE MEGLUMINEActive
Strength: 66 %
Monograph: DIATRIZOATE MEGLUMINE
DIATRIZOATE SODIUMActive
Strength: 10 %
Monograph: DIATRIZOATE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.